180 related articles for article (PubMed ID: 20355167)
1. Analysis of non-ketoic steroids 17alpha-methylepithiostanol and desoxymethyl- testosterone in dietary supplements.
Okano M; Sato M; Ikekita A; Kageyama S
Drug Test Anal; 2009 Nov; 1(11-12):518-25. PubMed ID: 20355167
[TBL] [Abstract][Full Text] [Related]
2. In vivo metabolism of the designer anabolic steroid hemapolin in the thoroughbred horse.
Waller CC; Weththasinghe SA; McClure L; Cawley AT; Suann C; Suann E; Sutherland E; Cooper E; Heather A; McLeod MD
Drug Test Anal; 2020 Jun; 12(6):752-762. PubMed ID: 31950580
[TBL] [Abstract][Full Text] [Related]
3. Detection and metabolic investigations of a novel designer steroid: 3-chloro-17α-methyl-5α-androstan-17β-ol.
Cawley AT; Blakey K; Waller CC; McLeod MD; Boyd S; Heather A; McGrath KC; Handelsman DJ; Willis AC
Drug Test Anal; 2016 Jul; 8(7):621-32. PubMed ID: 27443417
[TBL] [Abstract][Full Text] [Related]
4. Detection of designer steroid methylstenbolone in "nutritional supplement" using gas chromatography and tandem mass spectrometry: elucidation of its urinary metabolites.
Cavalcanti Gde A; Leal FD; Garrido BC; Padilha MC; de Aquino Neto FR
Steroids; 2013 Feb; 78(2):228-33. PubMed ID: 23200734
[TBL] [Abstract][Full Text] [Related]
5. Characterization of desoxymethyltestosterone main urinary metabolite produced from cultures of human fresh hepatocytes.
Gauthier J; Poirier D; Ayotte C
Steroids; 2012 May; 77(6):635-43. PubMed ID: 22366110
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometric description of novel oxymetholone and desoxymethyltestosterone metabolites identified in human urine and their importance for doping control.
Sobolevsky T; Rodchenkov G
Drug Test Anal; 2012 Sep; 4(9):682-91. PubMed ID: 22945829
[TBL] [Abstract][Full Text] [Related]
7. Determination of mepitiostane metabolites in human urine by liquid chromatography/tandem mass spectrometry for sports drug testing.
Okano M; Sato M; Kojima A; Kageyama S
J Pharm Biomed Anal; 2015 Nov; 115():236-44. PubMed ID: 26247800
[TBL] [Abstract][Full Text] [Related]
8. Seized designer supplement named "1-Androsterone": identification as 3β-hydroxy-5α-androst-1-en-17-one and its urinary elimination.
Parr MK; Opfermann G; Geyer H; Westphal F; Sönnichsen FD; Zapp J; Kwiatkowska D; Schänzer W
Steroids; 2011 May; 76(6):540-7. PubMed ID: 21310167
[TBL] [Abstract][Full Text] [Related]
9. Alternative markers for Methylnortestosterone misuse in human urine.
Sakellariou P; Kiousi P; Fragkaki AG; Lyris E; Petrou M; Georgakopoulos C; Angelis YS
Drug Test Anal; 2020 Nov; 12(11-12):1544-1553. PubMed ID: 32602999
[TBL] [Abstract][Full Text] [Related]
10. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine.
Sobolevsky T; Rodchenkov G
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):121-7. PubMed ID: 22142641
[TBL] [Abstract][Full Text] [Related]
11. Influences of musk administration on the doping test.
He Y; Wang J; Liu X; Xu Y; He Z
Steroids; 2013 Nov; 78(11):1047-52. PubMed ID: 23891647
[TBL] [Abstract][Full Text] [Related]
12. Combination of carbon isotope ratio with hydrogen isotope ratio determinations in sports drug testing.
Piper T; Emery C; Thomas A; Saugy M; Thevis M
Anal Bioanal Chem; 2013 Jun; 405(16):5455-66. PubMed ID: 23568614
[TBL] [Abstract][Full Text] [Related]
13. Another designer steroid: discovery, synthesis, and detection of 'madol' in urine.
Sekera MH; Ahrens BD; Chang YC; Starcevic B; Georgakopoulos C; Catlin DH
Rapid Commun Mass Spectrom; 2005; 19(6):781-4. PubMed ID: 15712284
[TBL] [Abstract][Full Text] [Related]
14. Detection of Δ6-methyltestosterone in a "dietary supplement" and GC-MS/MS investigations on its urinary metabolism.
Parr MK; Fusshöller G; Schlörer N; Opfermann G; Geyer H; Rodchenkov G; Schänzer W
Toxicol Lett; 2011 Mar; 201(2):101-4. PubMed ID: 21134425
[TBL] [Abstract][Full Text] [Related]
15. Analytical strategies for the detection of non-labelled anabolic androgenic steroids in nutritional supplements.
Parr MK; Geyer H; Reinhart U; Schänzer W
Food Addit Contam; 2004 Jul; 21(7):632-40. PubMed ID: 15370836
[TBL] [Abstract][Full Text] [Related]
16. Endocrine characterization of the designer steroid methyl-1-testosterone: investigations on tissue-specific anabolic-androgenic potency, side effects, and metabolism.
Parr MK; Blatt C; Zierau O; Hess C; Gütschow M; Fusshöller G; Opfermann G; Schänzer W; Diel P
Endocrinology; 2011 Dec; 152(12):4718-28. PubMed ID: 21990312
[TBL] [Abstract][Full Text] [Related]
17. Identification and quantification of metabolites common to 17alpha-methyltestosterone and mestanolone in horse urine.
Yamada M; Aramaki S; Okayasu T; Hosoe T; Kurosawa M; Kijima-Suda I; Saito K; Nakazawa H
J Pharm Biomed Anal; 2007 Sep; 45(1):125-133. PubMed ID: 17709226
[TBL] [Abstract][Full Text] [Related]
18. New oxymesterone metabolites in human by gas chromatography-tandem mass spectrometry and their application for doping control.
Yang S; Lu J; Xu Y; Wang X
Drug Test Anal; 2016 Jul; 8(7):633-43. PubMed ID: 26197789
[TBL] [Abstract][Full Text] [Related]
19. Metabolic study of methylstenbolone in horses using liquid chromatography-high resolution mass spectrometry and gas chromatography-mass spectrometry.
Choi TLS; Wong JKY; Kwok WH; Curl P; Mechie S; Wan TSM
J Chromatogr A; 2018 Apr; 1546():106-118. PubMed ID: 29548567
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive two-dimensional gas chromatography improves separation and identification of anabolic agents in doping control.
Mitrevski BS; Wilairat P; Marriott PJ
J Chromatogr A; 2010 Jan; 1217(1):127-35. PubMed ID: 19931865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
